BIOSONOMA
Live / Applied — Fourth extension granted (statement of use) (as of 25 Jul 2025)
What this means for you
Not registered yet, but its 14 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97503967
- Mark type
- Stylized text
- Filed
- 14 Jul 2022
- Published for opposition
- 06 Jun 2023
- Attorney of record
- Thad Chaloemtiarana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, cell therapy to treat diseases associated with inflammation such as autoimmune and neurodegenerative diseases, and biologic medications that reduce effector cells involved in diseases associated with inflammation such as autoimmune and neurodegenerative diseases
Owner
- Sonoma Biotherapeutics, Inc., South San Francisco, CA, US
- Sonoma Biotherapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 28 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jul 2025 — SOU EXTENSION 4 GRANTED
- 25 Jul 2025 — SOU EXTENSION 4 FILED
- 25 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Dec 2024 — SOU EXTENSION 3 GRANTED
- 20 Dec 2024 — SOU EXTENSION 3 FILED
- 20 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jun 2024 — SOU EXTENSION 2 GRANTED
- 19 Jun 2024 — SOU EXTENSION 2 FILED
- 19 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jan 2024 — SOU EXTENSION 1 GRANTED